Does GEFITINIB Cause Squamous cell carcinoma? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Squamous cell carcinoma have been filed in association with GEFITINIB (Gefitinib). This represents 0.3% of all adverse event reports for GEFITINIB.
15
Reports of Squamous cell carcinoma with GEFITINIB
0.3%
of all GEFITINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Squamous cell carcinoma From GEFITINIB?
Of the 15 reports, 2 (13.3%) required hospitalization.
Is Squamous cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEFITINIB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does GEFITINIB Cause?
Malignant neoplasm progression (1,651)
Drug resistance (1,228)
Death (590)
Diarrhoea (393)
Rash (318)
Metastases to central nervous system (306)
Acquired gene mutation (250)
Disease progression (244)
Drug ineffective (197)
Off label use (166)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which GEFITINIB Alternatives Have Lower Squamous cell carcinoma Risk?
GEFITINIB vs GELATIN
GEFITINIB vs GEMCITABINE
GEFITINIB vs GEMCITABINE\GEMCITABINE
GEFITINIB vs GEMFIBROZIL
GEFITINIB vs GEMTUZUMAB OZOGAMICIN